Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000514485 | SCV000332142 | uncertain significance | not provided | 2015-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087773 | SCV000558850 | benign | Fanconi anemia | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514485 | SCV000610288 | likely benign | not provided | 2017-05-04 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001087773 | SCV002534233 | likely benign | Fanconi anemia | 2021-10-13 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002518813 | SCV003715344 | uncertain significance | Inborn genetic diseases | 2021-12-07 | criteria provided, single submitter | clinical testing | The c.1658C>T (p.T553M) alteration is located in exon 8 (coding exon 6) of the FANCB gene. This alteration results from a C to T substitution at nucleotide position 1658, causing the threonine (T) at amino acid position 553 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003947831 | SCV004769312 | likely benign | FANCB-related disorder | 2019-04-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |